SEC Comment Letter for Cue Biopharma, Inc. (CUE) (CIK 0001645460) (CUE) — Jul 31, 2019

Cue Biopharma, Inc. (CUE) (CIK 0001645460)
Date: July 31, 2019 · CIK: 0001645460 · Accession: 0000000000-19-011864

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38327

Date

July 31, 2019

Author

Kerri-Ann Millar

Form

UPLOAD

Company

Cue Biopharma, Inc. (CUE) (CIK 0001645460)

Letter

July 31, 2019 Kerri-Ann Millar Vice President, Finance Cue Biopharma, Inc. 21 Erie St. Cambridge, MA 02139 Re:Cue Biopharma, Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed March 14, 2019 File No. 001-38327 Dear Ms. Millar: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

July 31, 2019
Kerri-Ann Millar
Vice President, Finance
Cue Biopharma, Inc.
21 Erie St.
Cambridge, MA 02139
Re:Cue Biopharma, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2018
Filed March 14, 2019
File No. 001-38327
Dear Ms. Millar:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io